Restoring a normal heart rhythm can hugely improve a patient's quality of life. SoGlos discovers more about a new treatment ...
ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback